Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Azacitidine in MDS/AML with Chromosome 7 Abnormalities
NCT00915785Phase 2Completed
- Sponsor
- King's College London
- Start
- Nov 2005
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), sponsored by King's College London. Started Nov 2005; status: completed.
02
Drugs
azacitidine
03
Conditions
myelodysplastic syndromes (MDS)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00915785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915785.